<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(27)</volume><submitter>Traberg WC</submitter><funding>Cambridge Trust</funding><pubmed_abstract>Tumor-derived extracellular vesicles (TEVs) induce the epithelial-to-mesenchymal transition (EMT) in nonmalignant cells to promote invasion and cancer metastasis, representing a novel therapeutic target in a field severely lacking in efficacious antimetastasis treatments. However, scalable technologies that allow continuous, multiparametric monitoring for identifying metastasis inhibitors are absent. Here, the development of a functional phenotypic screening platform based on organic electrochemical transistors (OECTs) for real-time, noninvasive monitoring of TEV-induced EMT and screening of antimetastatic drugs is reported. TEVs derived from the triple-negative breast cancer cell line MDA-MB-231 induce EMT in nonmalignant breast epithelial cells (MCF10A) over a nine-day period, recapitula</pubmed_abstract><journal>Advanced healthcare materials</journal><pagination>e2301194</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11468090</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Organic Electronic Platform for Real-Time Phenotypic Screening of Extracellular-Vesicle-Driven Breast Cancer Metastasis.</pubmed_title><pmcid>PMC11468090</pmcid><pubmed_authors>Hayward D</pubmed_authors><pubmed_authors>Koklu A</pubmed_authors><pubmed_authors>Fitzgerald R</pubmed_authors><pubmed_authors>Traberg WC</pubmed_authors><pubmed_authors>Lu Z</pubmed_authors><pubmed_authors>Owens RM</pubmed_authors><pubmed_authors>Hama A</pubmed_authors><pubmed_authors>Daniel S</pubmed_authors><pubmed_authors>Moysidou CM</pubmed_authors><pubmed_authors>Pappa AM</pubmed_authors><pubmed_authors>Inal S</pubmed_authors><pubmed_authors>Genovese AMR</pubmed_authors><pubmed_authors>Savva A</pubmed_authors><pubmed_authors>Uribe J</pubmed_authors><pubmed_authors>Huerta M</pubmed_authors><pubmed_authors>Pavagada S</pubmed_authors><pubmed_authors>McCoy R</pubmed_authors><pubmed_authors>Druet V</pubmed_authors></additional><is_claimable>false</is_claimable><name>Organic Electronic Platform for Real-Time Phenotypic Screening of Extracellular-Vesicle-Driven Breast Cancer Metastasis.</name><description>Tumor-derived extracellular vesicles (TEVs) induce the epithelial-to-mesenchymal transition (EMT) in nonmalignant cells to promote invasion and cancer metastasis, representing a novel therapeutic target in a field severely lacking in efficacious antimetastasis treatments. However, scalable technologies that allow continuous, multiparametric monitoring for identifying metastasis inhibitors are absent. Here, the development of a functional phenotypic screening platform based on organic electrochemical transistors (OECTs) for real-time, noninvasive monitoring of TEV-induced EMT and screening of antimetastatic drugs is reported. TEVs derived from the triple-negative breast cancer cell line MDA-MB-231 induce EMT in nonmalignant breast epithelial cells (MCF10A) over a nine-day period, recapitula</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2025-04-04T08:18:04.103Z</modification><creation>2025-04-04T08:18:04.103Z</creation></dates><accession>S-EPMC11468090</accession><cross_references><pubmed>37171457</pubmed><doi>10.1002/adhm.202301194</doi></cross_references></HashMap>